Skip to main content
Press release June 15, 2026

GENFIT: June 15, 2026 Combined Shareholders Meeting Results

SA GENFIT (GNFT)

All resolutions recommended by the Board of Directors approved (quorum: 32.13%) Lille (France); Cambridge, ( Massachusetts, United States); Zurich (Switzerland); June 15, 2026 - GENFIT (Euronext: GNFT),, a biopharmaceutical company dedicated to improving the lives of patients with rare and
View original release